AIM ImmunoTech
33 hedge funds and large institutions have $3.15M invested in AIM ImmunoTech in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
63% more capital invested
Capital invested by funds: $1.93M → $3.15M (+$1.22M)
18% more funds holding
Funds holding: 28 → 33 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.73M |
| 2 |
TSS
Two Sigma Securities
New York
|
+$44K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$41.6K |
| 4 |
VF
Virtu Financial
New York
|
+$23.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$11.3K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$8.49K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7.93K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$7.64K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$245 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $370 | – | – | – |
|
|
AF
27
Advisornet Financial
Minnetonka,
Minnesota
| $186 | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $146 | +$170 | +4 | New |
|
|
CC
29
Cypress Capital
Franklin,
Tennessee
| $75 | +$85 | +2 | New |
|
|
TWC
30
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $63 | +$85 | +2 | New |
|
31
JP Morgan Chase
New York
| $43 | – | – | – |
|
|
HNB
32
Huntington National Bank
Columbus,
Ohio
| $21 | – | – | – |
|
|
DS
33
DRW Securities
Chicago,
Illinois
| – | -$11.3K | -240 | Closed |
|
|
34
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$7.93K | -168 | Closed |
|
|
35
Fidelity Investments
Boston,
Massachusetts
| – | -$245 | -5 | Closed |
|
AIM Hedge Fund Activity: Q2 2024 in Review
33 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2024, worth a combined $3.15M — up 63% from $1.93M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AIM positions and 3 closed out — a net gain of 5 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.73M. The largest seller was DRW Securities, exiting entirely with an estimated $11.3K sold.
- 33 institutional investors held AIM ImmunoTech (AIM) as of Q2 2024, up from 28 in Q1 2024.
- Funds reported $3.15M of AIM ImmunoTech stock for Q2 2024, up 63% quarter-over-quarter.
- 8 funds opened new AIM ImmunoTech positions in Q2 2024 and 3 closed out, a net change of +5 holders.
- The largest AIM ImmunoTech buyer in Q2 2024 was Armistice Capital, an estimated $1.73M added.
- The largest AIM ImmunoTech seller in Q2 2024 was DRW Securities, an estimated $11.3K sold.
Based on aggregated 13F filings for Q2 2024.